A phase 1/2 study of orally administered synthetic hypericin for treatment of recurrent malignant gliomas-Reference-Cited by-同舟云学术

A phase 1/2 study of orally administered synthetic hypericin for treatment of recurrent malignant gliomas

Published:2011-03-31 Issue:21 Volume:117 Page:4905-4915
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Couldwell William T.,Surnock Amy A.,Tobia Alfonso J.,Cabana Bernard E.,Stillerman Charles B.,Forsyth Peter A.,Appley Alan J.,Spence Alexander M.,Hinton David R.,Chen Thomas C.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference27 articles.

1. Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin;Lavie;Proc Natl Acad Sci U S A,1989

2. Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John's wort plant, in patients with chronic hepatitis C virus infection;Jacobson;Antimicrob Agents Chemother,2001

3. Protein kinase C activity correlates with the growth rate of malignant gliomas: part II. Effects of glioma mitogens and modulators of protein kinase C;Couldwell;Neurosurgery,1992

4. Hypericin: a potential antiglioma therapy;Couldwell;Neurosurgery,1994

5. Enhanced ubiquitinylation of heat shock protein 90 as a potential mechanism for mitotic cell death in cancer cells induced with hypericin;Blank;Cancer Res,2003

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging of heterogeneity in 3D spheroids of U87MG glioblastoma cells and its implications for photodynamic therapy;Photodiagnosis and Photodynamic Therapy;2023-12

2. New findings on the action of hypericin in hypoxic cancer cells with a focus on the modulation of side population cells;Biomedicine & Pharmacotherapy;2023-07

3. Hypericin: A natural anthraquinone as promising therapeutic agent;Phytomedicine;2023-03

4. Hypericin and its anticancer effects: From mechanism of action to potential therapeutic application;Phytomedicine;2022-10

5. Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review;Journal of Neuro-Oncology;2022-08-06